Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

EMA accepts for review MAA for adalimumab biosimilar, FKB-327

May 22, 2017

Symic reports topline results from phase I/IIa study of SB-061 for osteoarthritis of the knee

May 19, 2017

Development of cell-mediated gene therapy Invossa updated at ASCGT

May 16, 2017

Cytokinetics' CK-2127107 named FDA orphan drug for SMA

May 16, 2017

Seikagaku and Ono enter codevelopment and marketing collaboration on SI-613

May 15, 2017

FLX-787 demonstrates clinical benefit for treating nocturnal leg cramping

May 5, 2017

FDA accepts for review Xeljanz sNDAs for psoriatic arthritis

May 4, 2017

GlaxoSmithKline divulges BRD4 inhibitors

May 2, 2017

Trial finds urolithin A safe in healthy elderly subjects

May 2, 2017

Kyowa Hakko Kirin initiates global phase III trial of brodalumab in axial spondyloarthritis

April 26, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...